Evidence map›Paper›PMID 24739570›Full record

ArticleNeural development2014

LPHN3, a presynaptic adhesion-GPCR implicated in ADHD, regulates the strength of neocortical layer 2/3 synaptic input to layer 5.

Matthew L O'Sullivan, Francesca Martini, Sventja von Daake, Davide Comoletti, Anirvan Ghosh

Open access · goldAbstract read
In one paragraph

Article in Neural development, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review of rodent models of attention deficit hyperactivity disorder.Neuroscience and biobehavioral reviews · 2022
    Review
  14. Article
  15. Latrophilin-3 disruption: Effects on brain and behavior.Neuroscience and biobehavioral reviews · 2021
    Review
  16. Article
  17. FLRTing Neurons in Cortical Migration During Cerebral Cortex Development.Frontiers in cell and developmental biology · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Matthew L O'Sullivan
Francesca Martini
Sventja von Daake
Davide Comoletti
Anirvan GhoshNeurobiology Section, Division of Biology, University of California San Diego, La Jolla, CA 92093, USA. anirvan.ghosh@roche.com.
Rutgers, The State University of New Jersey · USRoche (Switzerland) · CHUniversity of California, San Diego · US

Funding

Caspr2 as an autism candidate gene: a proteomic approach to function & structure.R01MH092906 · NIMH · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI COMOLETTI, DAVIDE · 2011 to 2015
$1.6M
Role of AMPA Receptor Reverse Signaling in Synapse StabilityR01NS064124 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, ANIRVAN · 2009 to 2012
$1.3M
REGULATION OF GLUTAMATERGIC SYNAPSES BY LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEINR01NS067216 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, ANIRVAN · 2010 to 2013
$1.3M
NIMH NIH HHS R01-MH092906NINDS NIH HHS R01 NS064124NINDS NIH HHS R01 NS067216
6 · The paper itself

Abstract

backgroundLatrophilins (LPHNs) are a small family of neuronal adhesion-GPCRs originally discovered as receptors for the black widow spider toxin α-latrotoxin. Mutations in LPHN3 have recently been identified as risk factors for attention deficit hyperactivity disorder (ADHD) in humans, but their physiological function has remained elusive. In this study, we tested two hypotheses regarding LPHN3 function: (1) LPHN3 regulates synaptic transmission by modulating probability of release; and (2) LPHN3 controls synapse development and the abundance of synapses.

resultsWe manipulated LPHN3 expression in mouse layer 2/3 (L2/3) pyramidal neurons and examined the consequences on the L2/3 to L5 cortical microcircuit. Employing an optogenetic strategy combined with shRNA knockdown of LPHN3, we found that LPHN3 did not influence probability of release at synapses formed by L2/3 neurons onto L5 pyramidal cells. The strength of L2/3 afferent input to L5, however, was weakened by loss of LPHN3. Using Synaptophysin-GFP as an anatomical marker of presynaptic terminals, we found that the density of synapses formed by L2/3 axons in L5 was reduced when LPHN3 was lost. Finally, we investigated the structural organization of the extracellular domain of LPHN3. We used single particle negative stain electron microscopy to image the extracellular domain of LPHN3 and showed that the Olfactomedin and Lectin domains form a globular domain on an elongated stalk. Cell-based binding experiments with mutant proteins revealed that the Olfactomedin domain was required for binding to FLRT3, whereas both the Olfactomedin and Lectin domains were involved in binding to Teneurin 1. Mutant LPHN3 lacking the Olfactomedin domain was not capable of rescuing the deficit in presynaptic density following knockdown of endogenous LPHN3.

conclusionsWe find that LPHN3 regulates the number of synapses formed by L2/3 neurons in L5 and the strength of synaptic drive from the L2/3-L5 pathway. The Olfactomedin domain of LPHN3 is required for this effect on synapse number and binding to its postsynaptic ligand FLRT3. We propose that LPHN3 functions in synaptic development and is important in determining the connectivity rates between principal neurons in the cortex.

Indexed as

Excitatory Postsynaptic PotentialsAnimalsCerebral CortexMiceReceptors, G-Protein-CoupledReceptors, PeptideSynapsesAdgrl3 protein, mouseReceptors, G-Protein-CoupledReceptors, Peptide

Identifiers

PMID24739570
PMCPMC3996519
OpenAlexW2107282780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.